The first molecular analysis of a Hungarian HNPCC family: A novel MSH2 germline mutation;Az elso magyar hereditaer nem polypoticus colorectalis carcinoma család molekuláris vizsgálata: Az MSH2 gén új mutációja

Orvosi Hetilap

Volumn 146, Issue 20, 2005, Pages 1009-1016

  Czakó, László ^a,c   Tiszlavicz, László ^b   Takács, Róbert ^a   Baradnay, Gellért ^a   Lonovics, János ^a   Cserni, Gábor ^c   Katarina, Závodná ^d   Zdena, Bartosova ^d  

^a UNIVERSITY OF SZEGED   (Hungary)

^b Patológiai Intézet   (Hungary)

^c Sebészeti Klinika ^*  (Hungary)

^d CANCER RESEARCH INSTITUTE   (Slovakia)

Author keywords

Baso squamous cell cancer; Germline mutations; Hereditary nonpolyposis colorectal cancer; Microsatellite instability; Mismatch repair; MLH1; MSH2; Squamous cell cancer

Indexed keywords

PROTEIN MLH1; PROTEIN MSH2; PROTEIN P53; TRYPTOPHAN; TUMOR SUPPRESSOR PROTEIN; CARRIER PROTEIN; DNA; DNA BINDING PROTEIN; MICROSATELLITE DNA; MLH1 PROTEIN, HUMAN; MSH2 PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN; TUMOR PROTEIN;

ADULT; ANAMNESIS; CASE REPORT; COLORECTAL CANCER; DNA FLANKING REGION; DNA SCREENING; DNA SEQUENCE; EXON; FEMALE; GENE MUTATION; HUMAN; HUNGARY; IMMUNOHISTOCHEMISTRY; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; PROTEIN EXPRESSION; REVIEW; STOP CODON; AGED; ARTICLE; BASAL CELL CARCINOMA; BASE MISPAIRING; COLORECTAL TUMOR; DECISION TREE; DNA REPAIR; ENDOMETRIUM TUMOR; GENETIC SCREENING; GENETICS; MALE; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; PEDIGREE; SQUAMOUS CELL CARCINOMA;

AGED; BASE PAIR MISMATCH; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DECISION TREES; DNA MUTATIONAL ANALYSIS; DNA REPAIR; DNA, NEOPLASM; DNA-BINDING PROTEINS; ENDOMETRIAL NEOPLASMS; FEMALE; GENETIC SCREENING; GERM-LINE MUTATION; HUMANS; HUNGARY; IMMUNOHISTOCHEMISTRY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PEDIGREE; PROTO-ONCOGENE PROTEINS;

EID: 22144486617     PISSN: 00306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Alexander, J., Watanabe, T., Wu, T. T. és mtsai: Histopathological identification of colon cancer with microsatellite instability. Am. J. Pathol., 2001, 158, 527-535.
2. Allegra, C. J., Kim, G., Kirsch, I. R.: Microsatellite instability in colon cancer. N. Engl. J. Med., 2003, 349, 1774-1776.
3. American Gastroenterology Association: AGA médical position statement: hereditary colorectal cancer and genetic testing. Gastroenterology, 2001, 121, 195-197.
4. American Gastroenterology Association: AGA technical review on hereditary colorectal cancer and genetic testing. Gastroenterology, 2001, 121, 198-213.
5. Bartosova, Z., Fridrichova, I., Bujalkova, M.: Novel MLH1 and MSH2 germline mutations in the first HNPCC families identified in Slovakia. Human Mutation, 2003, 21, 449-453.
6. Boland, C. R., Thibodeau, S. N., Hamilton, S. R. és mtsai: A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Research, 1998, 58, 5248-5257.
7. Cawkwell, L., Gray, S., Murgatroyd, H.: Choice of management strategy for colorectal cancer based on a diagnostic immunohistochemical test for defective mismatch repair. Gut, 1999, 45, 409-415.
8. Chung, D. C., Rustgl, A. K.: The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications. Ann. Intern. Med., 2003, 138, 560-570.
9. Church, J. M.: Prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer. Ann. Med., 1996, 28, 479-482.
10. den Dunnen, J. T., Antonarakis, S. E.: Mutation nomenclature extension and suggestions to describe complex mutations: a discussion. Human Mutat, 2000, 15, 7-12.
11. den Dunnen, J. T., Antonarakis, S. E.: Nomenclature for the description of human sequence variations. Human Genet, 2001, 109, 121-124.
12. Elsaleh, H., Powell, B., McCaul, K. és mtsai: P53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma. Clin. Cancer Res., 2001, 7, 1343-1349.
13. Elsaleh, H., Joseph, D., Grieu, F. és mtsai: Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer. Lancet, 2000, 355, 1745-1750.
14. Gryfe, R., Kim, H., Hsieh, E. T. és mtsai: Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N. Engl. J. Med., 2000, 342, 69-77.
15. Hemminki, A., Mecklin, J. P., Jarvinen, H. és mtsai: Microsatellite instability is a favorable prognostic indicator in patients with colorecal cancer receiving chemotherapy. Gastroenterology, 2000, 119, 921-928.
16. Jagadeesh, D., Syngal, S.: Genetic testing for hereditary non-polyposis colorectal cancer. Curr. Op. Gastroenterol., 2003, 19, 57-63.
17. Järvinen, H. J., Aarnio, M., Mustonen, H. és mtsai: Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology, 2000, 118, 829-834.
18. Jemal, A., Thomas, A., Murray, T. és mtsai: Cancer statistics, 2002. CA Cancer J. Clin., 2002, 52, 23-47.
19. Lindor, N. M., Burgart, L. J., Leontovich, O. és mtsai: Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J. Clin. Oncol., 2002, 20, 1043-1048.
20. Lynch, H. T., de la Chapelle A.: Hereditary colorectal cancer. N. Engl. J. Med., 2003, 345, 919-932.
21. Lynch, H. T., Lanspa, S. J., Boman, B. M.: Hereditary nonpolyposis colorectal cancer - Lynch syndromes I and II. Gastroenterol Clin. North. Am., 1988, 17, 679-711.
22. Lynch, H. T.: Is there a role for prophylactic subtotal colectomy among hereditary nonpolyposis colorectal cancer germline mutation carriers? Dis. Colon. Rectum, 1996, 39, 109-110.
23. Meira, L. B., Cheo, D. L., Reis, A. M. és mtsai: Mice defective in the mismatch repair gene Msh2 show increased predisposition to UVB radiation-induced skin cancer. DNA Repair (Amst.), 2002, 1, 929-934.
24. Ravnik-Glavac, M., Potocnik, U., Glavac D.: Incidence of germline hMLH1 and hMSH2 mutations (HNPCC patients) among newly diagnosed colorectal cancers in a Slovenian population. J. Med. Genet., 2000, 37, 533-536.
25. Ramsey, S. D., Clarke, L., Etzioni, R. és mtsai: Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary non-polyposis colorectal cancer. Ann. Intern. Med., 2001, 135, 577-588.
26. Ribic, C. M., Sargent, D. J., Moore, M. J.: Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N. Engl. J. Med., 2003, 349, 247-257.
27. Rodriguez-Bigas, M. A., Boland, C. R., Hamilton, S. R. és mtsai: A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meetings highlights and Bethesda guidelines. J. Natl. Cancer. Inst., 1997, 89, 1758-1762.
28. Salovaara, R., Loukola, A., Kristo, P. És mtsai: Population-based molecular detection of hereditary nonpolyposis colorectal cancer. J. Clin. Oncol., 2000, 18, 2193-2200.
29. Samowitz, W. S., Curtin, K., Lin, H. H. és mtsai: The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. Gastroenterology, 2001, 121, 830-838.
30. Syngal, S., Fox, E. A., Eng, C. és mtsai: Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSh2 and MLH1. J. Med. Genet., 2000, 37, 641-645.
31. Terdiman, J.P., Gum, J.R., Conrad, P.G. és mtsai: Efficient detection of hereditary non-polyposis colorectal cancergene carriers by screening for tumor microsatellite instability before germline genetic testing. Gastroenterology, 2001, 120, 21-30.
32. Tiszlavicz L., Hódi, Zs., Tihanyi Z.: Muir-Torre- szindróma. Orv. Hetil, 1999, 140, 251-254.
33. http://www.nfdht.nl (hozzáférés dátuma: 2004. augusztus 5.)
34. Umar, A., Risinger, J. I., Hawk, E. T. és mtsai: Testing guidelines for hereditary non-polyposis colorectal cancer. Nat. Rev. Cancer., 2004, 4, 153-158.
35. Vasen, H. F., Mecklin, J. P., Khan, P. M. és mtsai: The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer (ICG-HNPCC). Dis. Colon. Rectum., 1991, 34, 424-425.
36. Vasen, H. F., Watson, P., Mecklin, J. P. és mtsai: New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology, 1999, 116, 1453-1456.
37. Vasen, H. F., Wijnen, J. T., Menko, F. H. és mtsai: Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology, 1996, 110, 1020-1027.
38. Wiillenweber, H. P., Sutter, C., Autschbach, F. és mtsai: Evaluation of Bethesda guidelines in relation to microsatellite instability. Dis Colon Rectum, 2001, 44, 1281-1289.